UBS Group’s Innovator U.S. Equity Accelerated ETF - January XDJA Stock Holding History

UBS Group’s Portfolio XDJA Stock Details XDJA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-799	Closed	-$22.8K	–	11088
2024 Q4	$22.8K	Buy	799 +348	+77%	+$9.82K	﹤0.01%	7792
2024 Q3	$12.6K	Buy	451 +250	+124%	+$6.85K	﹤0.01%	7629
2024 Q2	$5.46K	Buy	201 +157	+357%	+$4.15K	﹤0.01%	7996
2024 Q1	$1.16K	Sell	44 -492	-92%	-$12.5K	﹤0.01%	8213
2023 Q4	$13.1K	Buy	536 +299	+126%	+$7.12K	﹤0.01%	7327
2023 Q3	$5.47K	Buy	+237	New	+$5.52K	﹤0.01%	7367
2023 Q1	–	Sell	-1,595	Closed	-$31.4K	–	11570
2022 Q4	$31.4K	Buy	+1,595	New	+$31.5K	﹤0.01%	7193
2022 Q3	–	Sell	-1,363	Closed	-$26K	–	11849
2022 Q2	$26K	Buy	1,363 +26	+2%	+$551	﹤0.01%	6586
2022 Q1	$32K	Buy	+1,337	New	+$31K	﹤0.01%	6950

UBS Group's XDJA Position: Q1 2025 in Review

UBS Group sold out of Innovator U.S. Equity Accelerated ETF - January (XDJA) in Q1 2025, closing a stake of 799 shares — an estimated $22.8K sold.

UBS Group first reported a position in XDJA in Q1 2022 and held it in 9 quarters. The position peaked at $32K in Q1 2022. 0 funds tracked by Wall St. Rank hold XDJA as of Q1 2025.

UBS Group reported no remaining Innovator U.S. Equity Accelerated ETF - January position as of Q1 2025 after selling out during the quarter.
UBS Group sold 799 Innovator U.S. Equity Accelerated ETF - January shares in Q1 2025, an estimated $22.8K.
UBS Group first reported a position in Innovator U.S. Equity Accelerated ETF - January in Q1 2022 and held it in 9 quarters.
UBS Group's Innovator U.S. Equity Accelerated ETF - January position peaked at $32K in Q1 2022.
0 funds tracked by Wall St. Rank held Innovator U.S. Equity Accelerated ETF - January as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.